Intensity-Modulated Proton Therapy Versus Intensity-Modulated Radiotherapy for Inoperable Esophageal Squamous Cell Carcinoma: Methodologic Issues
Journal of Thoracic Oncology · 2024
DOI: 10.1016/j.jtho.2024.01.008 ↗Kurz gefasst
Leserbrief in der Zeitschrift Journal of Thoracic Oncology, 2024. Verfasst von Chi-Chuan Chiou und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Heavy Particles & Radiation Oncology, Taipei Veterans General Hospital, Taipei, Taiwan. Hauptthemen laut MEDLINE: Esophageal Squamous Cell Carcinoma, Radiotherapy, Intensity-Modulated, Esophageal Neoplasms, Proton Therapy. Die Arbeit nennt 3 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Heavy Particles & Radiation Oncology, Taipei Veterans General Hospital, Taipei, Taiwan.
- Department of Heavy Particles & Radiation Oncology, Taipei Veterans General Hospital, Taipei, Taiwan; School of Medicine, National Yang Ming Chao Tung University, Taipei, Taiwan; Institute of Public Health, National Yan…
Zitieren
APA
Chiou, C. C., & Lai, T. Y. (2024). Intensity-Modulated Proton Therapy Versus Intensity-Modulated Radiotherapy for Inoperable Esophageal Squamous Cell Carcinoma: Methodologic Issues. Journal of Thoracic Oncology. https://doi.org/10.1016/j.jtho.2024.01.008
Vancouver
Chiou CC, Lai TY. Intensity-Modulated Proton Therapy Versus Intensity-Modulated Radiotherapy for Inoperable Esophageal Squamous Cell Carcinoma: Methodologic Issues. Journal of Thoracic Oncology. 2024. doi:10.1016/j.jtho.2024.01.008
BibTeX
@article{Chiou2024,
author = {Chiou, Chi-Chuan and Lai, Tzu-Yu},
title = {Intensity-Modulated Proton Therapy Versus Intensity-Modulated Radiotherapy for Inoperable Esophageal Squamous Cell Carcinoma: Methodologic Issues},
journal = {Journal of Thoracic Oncology},
year = {2024},
doi = {10.1016/j.jtho.2024.01.008}
}
EUVIMED